Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

4.29
Delayed Data
As of Feb 24
 +0.10 / +2.39%
Today’s Change
2.63
Today|||52-Week Range
6.30
+18.51%
Year-to-Date
Intercept (ICPT) Q4 Loss Wider than Expected, Revenues Beat
Feb 24 / Zacks.com - Paid Partner Content
ImmunoGen Posts Wider-than-Expected Loss; Sales Down Y/Y
Feb 20 / Zacks.com - Paid Partner Content
Emergent (EBS) Beats Earnings, Revenue Estimates in Q4
Feb 24 / Zacks.com - Paid Partner Content
Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
Feb 17 / Zacks.com - Paid Partner Content
Radius Health (RDUS) Posts Wider Loss in Q4
Feb 24 / Zacks.com - Paid Partner Content
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
Feb 17 / Zacks.com - Paid Partner Content
Bayer (BAYRY) Misses on Q4 Earnings; Revenues in Line
Feb 23 / Zacks.com - Paid Partner Content
Agios Pharma (AGIO) Q4 Loss Narrower than Expected; Stock Up
Feb 17 / Zacks.com - Paid Partner Content
Pfizer's Leukemia Candidate Gets Priority Review in U.S.
Feb 22 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook
Feb 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close4.19
Today’s open4.25
Day’s range4.11 - 4.33
Volume62,655
Average volume (3 months)59,817
Market cap$89.6M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+34.21%
Earnings growth (this year)+18.56%
Earnings growth (next 5 years)--
Revenue growth (last year)-46.62%
P/E ratioNM
Price/Sales21.38
Price/Book5.66

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc-0.01-0.79%
CPRXCatalyst Pharmaceuti...0.000.00%
CPIXCumberland Pharmaceu...-0.05-0.88%
SYNSynthetic Biologics ...+0.01+1.17%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$3.1M
Annual profit (last year)-$36.7M
Net profit margin-1,198.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs